STERIS plc

NYSE:STE

Location

Market Cap

USD 23.85 B

Share Price

USD 241.34

Avg Daily Volume

657,768

Change (1 day)

-0.44%

Change (1 year)

9.18%

Change (YTD)

17.41%

STERIS plc Price to Book Ratio (P/B) on June 13, 2025

STERIS plc Price to Book Ratio (P/B) is NA on June 13, 2025. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • STERIS plc 52-week low Price to Book Ratio (P/B) is 3.89 on June 13, 2025, which is NA below the current Price to Book Ratio (P/B).
  • STERIS plc 52-week low Price to Book Ratio (P/B) is 3.11 on June 13, 2025, which is NA below the current Price to Book Ratio (P/B).
  • STERIS plc average Price to Book Ratio (P/B) for the last 52 weeks is 3.50.
Key data
Date Price to Book Ratio (P/B) Price to Sales Ratio (P/S) Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield
Market news
Loading...
NYSE: STE

STERIS plc

CEO Mr. Daniel A. Carestio
IPO Date June 1, 1992
Location Ireland
Headquarters 70 Sir John Rogerson's Quay
Employees 18,000
Sector 🏥 Health Care
Industries
Description

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Similar companies

PODD

Insulet Corporation

USD 304.63

0.33%

BRKR

Bruker Corporation

USD 38.30

-3.94%

CNMD

CONMED Corporation

USD 53.55

-2.58%

LIVN

LivaNova PLC

USD 45.76

-1.87%

SYK

Stryker Corporation

USD 377.30

-0.84%

MASI

Masimo Corporation

USD 161.20

-2.50%

ITGR

Integer Holdings Corporation

USD 118.30

-0.38%

PEN

Penumbra, Inc.

USD 256.50

1.22%

BSX

Boston Scientific Corporation

USD 99.74

1.20%

ZIMV

ZimVie Inc.

USD 9.10

-1.94%

IRTC

iRhythm Technologies, Inc.

USD 143.85

-1.12%

ANIK

Anika Therapeutics, Inc.

USD 10.93

-3.02%

GKOS

Glaukos Corporation

USD 97.60

0.00%

OFIX

Orthofix Medical Inc.

USD 11.00

-1.43%

StockViz Staff

June 16, 2025

Any question? Send us an email